Moneycontrol
HomeNewsBusinessSpiceJet gets ready to distribute COVID-19 vaccines, with over a dozen MoUs under its belt
Trending Topics

SpiceJet gets ready to distribute COVID-19 vaccines, with over a dozen MoUs under its belt

The vaccine distribution, led by cargo unit SpiceXpress, may turn out to be critical to improve the airline's net worth and financial health

January 06, 2021 / 13:53 IST
Story continues below Advertisement

Spicejet interest cost for FY20 was Rs 546 crore, while the operating profit for the same fiscal was Rs 514 crore.

With preparations almost on a far footing, including over a dozen MoUs signed in less than two months, SpiceJet may have readied the most extensive network to deliver vaccines for any airline in India.

It is also a calculative risk, that some observers call opportunistic. If successful, delivering vaccines across the country may also keep Ajay Singh's core aviation business, which like its peers is yet to reach anywhere close to pre-COVID-19 levels, afloat.

Story continues below Advertisement

The low-cost airline is driving the initiative through its cargo unit SpiceXpress, which has already proved its usefulness by limiting losses for the airline by clocking revenues of about Rs 550 crore in the first six months of the financial year.

The cargo vertical, which had floated a new unit Spice Pharma Pro to drive the vaccine business, is also working in tandem with SpiceHealth, the private initiative of the Singh family that will be the last stop in the whole supply chain to administer the doses.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show